Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TRAW stock hub

Traws Pharma, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TRAWis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TRAW

In the news

Latest news · TRAW

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E2.6

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TRAW market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001130598
Company name	Traws Pharma, Inc.
Country	United States
Country code	US
Cusip	68232V884
Employees	7
Employees Change	-11%
Employees Change Percent	-61.11
Enterprise value	$18.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-07-25
Isin	US68232V8845
Last refreshed	2026-05-10
Market cap	$22.1M
Market cap category	Nano-Cap
Price	$2.18
Price currency	USD
Rev Per Employee	398,571.43x
Sector	Healthcare
Sic	2834
Symbol	TRAW
Website	https://www.trawspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	31%
EV Earnings	2.67x
EV/Sales	6.57x
FCF yield	-82.13%
P/E ratio	2.61x
P/S ratio	7.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$2.8M
Gross Profit Growth	1,134.51%
Gross Profit Growth3 Y	131.12%
Gross Profit Growth5 Y	64.59%
Net Income	$6.9M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	328.67%
Profit Margin	328.67%
Profit Per Employee	$980,714
Profitable Years	1
ROA	-62.8
Roa5y	-44.45
ROCE	3,379

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-60.12%
Cagr1y	54.66%
Cagr3y	-60.35%
Cagr5y	-60.38%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	1,134.51x
Revenue Growth Years	1x
Revenue Growth3 Y	131.12x
Revenue Growth5 Y	64.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.16
Assets	$10.6M
Cash	$3.8M
Current Assets	$8M
Current Liabilities	$11.1M
Equity	$-629,000
Liabilities	$11.2M
Long Term Assets	$2.6M
Long Term Liabilities	$100,000
Net Cash	$3.8M
Net Cash By Market Cap	$17.25
Net Cash Growth	-82.1%
Tangible Book Value	$-3.2M
Tangible Book Value Per Share	$-0.35
WACC	12.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.72
Net Working Capital	$-7M
Quick ratio	0.68
Working Capital	$-3.2M
Working Capital Turnover	$0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-429.93%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	54.61%
200-day SMA	1.88
3Y total return	-93.77%
50-day SMA	1.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.02%
All Time High	1,751,060.3
All Time High Change	-100%
All Time High Date	2013-10-04
All Time Low	0.97
All Time Low Change	124.74%
All Time Low Date	2025-05-15
ATR	0.21
Beta	1.47
Beta1y	-1.51
Beta2y	0.07
Ch YTD	92.92
High	2.4
High52	3.27
High52 Date	2025-10-10
High52ch	-33.23%
Low	1.79
Low52	0.97
Low52 Date	2025-05-15
Low52ch	124.74%
Ma50ch	31.09%
Premarket Change Percent	22.35
Premarket Price	$2.08
Premarket Volume	39,719,208
Price vs 200-day SMA	15.96%
RSI	73.05
RSI Monthly	27.63
RSI Weekly	54.27
Sharpe ratio	0.93x
Sortino ratio	1.55
Total Return	-429.93%
Tr YTD	92.92
Tr1m	36.25%
Tr1w	46.31%
Tr3m	11.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.52
Operating Income	$-17.9M
Operating margin	-640.7
Price target	$8
Price Target Change	$267

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,364,589%
Float Percent	52.82%
Shares Insiders	8.49%
Shares Institutions	6.95%
Shares Out	10,157,257
Shares Qo Q	6.11%
Shares Yo Y	429.93%
Short Float	7.56%
Short Ratio	3.32
Short Shares	3.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.9M
Average Volume	4,717,170x
Bv Per Share	-0.07
Ch10y	-99.99
Ch1m	36.25
Ch1w	46.31
Ch1y	54.61
Ch3m	11.22
Ch3y	-93.77
Ch5y	-99.02
Ch6m	11.8
Change	28.24%
Change From Open	6.34
Close	1.7
Days Gap	20.59
Depreciation Amortization	61,000
Dollar Volume	195,104,604.5
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-17.9M
EBITDA	$-17.8M
EPS	$0.83
F Score	2
FCF	$-18.2M
FCF EV Yield	-99.25x
FCF Per Share	$-1.79
Financing CF	3,204,000
Fiscal Year End	December
Founded	1,998
Investing CF	-2,585,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-15
Last Report Date	2025-12-31
Last Split Date	2024-09-23
Last Split Type	Reverse
Last10k Filing Date	2026-04-15
Ma150	1.95
Ma150ch	11.62%
Ma20	1.42
Ma20ch	53.09%
Net CF	-17,518,000
Next Earnings Date	2026-05-22
Open	2.05
Optionable	No
Position In Range	63.93
Post Close	2.18
Postmarket Change Percent	-6.88
Postmarket Price	$2.03
Ppne	7,000
Pre Close	1.7
Price Date	2026-05-08
Relative Volume	18.97x
Revenue	2,790,000x
SBC By Revenue	26.09x
Share Based Comp	728,000
Tr6m	11.8%
Us State	Pennsylvania
Views	71
Volume	89,497,525
Z Score	-89.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TRAW pay a dividend?

Capital-return profile for this ticker.

Performance

TRAW stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TRAW?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.0%

Float: +52.8% of shares outstanding

Insider ownership

+8.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TRAW momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.0

Above 70: short-term overbought

Price vs 200-day MA

+16.0%

50/200-day relationship not available

Beta (5Y)

1.47

More volatile than the market

Sharpe ratio

0.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TRAW

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TRAW stock rating?

Traws Pharma, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TRAW analysis?

The full report lives at /stocks/TRAW/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TRAW?

The latest report frames TRAW around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TRAW page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.